bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Avant-garde‚Äã: An automated data-driven DIA data curation tool.
Alvaro Sebastian Vaca Jacome‚Äã1‚Äã, Ryan Peckner‚Äã1‚Äã, Nicholas Shulman‚Äã2‚Äã, Karsten Krug‚Äã1‚Äã, Katherine
C. DeRuff‚Äã1‚Äã, Adam Officer‚Äã1‚Äã, Brendan MacLean‚Äã2‚Äã, Michael J. MacCoss‚Äã2‚Äã, Steven A. Carr‚Äã1‚Äã, Jacob D.
Jaffe‚Äã1
1 Broad Institute of MIT and Harvard, Cambridge
2 University of Washington Genome Sciences, Seattle, WA

Abstract
Data-Independent Acquisition (DIA) is a technique that promises to comprehensively detect and
quantify all peptides above an instrument‚Äôs limit of detection. Several software tools to analyze
DIA data have been developed in recent years. However, several challenges still remain, like
confidently identifying peptides, defining integration boundaries, dealing with interference for
selected transitions, and scoring and filtering of peptide signals in order to control false
discovery rates. In practice, a visual inspection of the signals is still required, which is
impractical with large datasets. ‚ÄãAvant-garde is a new tool to refine DIA (and PRM) by removing
interfered transitions, adjusting integration boundaries and scoring peaks to control the FDR.
Unlike other tools where MS runs are scored independently from each other, ‚ÄãAvant-garde uses
a novel data-driven scoring strategy. DIA signals are refined by learning from the data itself,
using all measurements in all samples together to achieve the best optimization. We evaluated
the performances of ‚ÄãAvant-garde with a calibrated sample using spiked-in standards in a
complex background, a phospho-enriched dataset (Abelin ‚Äãet al‚Äã, 2016), and two complex hybrid
proteome samples for benchmarking DIA software tools. ‚ÄãThe results clearly showed that
Avant-garde ‚Äãis capable of improving the selectivity, accuracy, and reproducibility of the
quantification results in very complex biological matrices. We have further shown that it can
evaluate the suitability of a peak to be used for quantification reaching the same levels of
selectivity, accuracy, and reproducibility obtained with manual validation.

1

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Introduction
Quantitative proteomics is a fundamental tool to decode the complexity and the dynamics of the
proteome. Data-Independent Acquisition (DIA) is a family of newly-developed LCMS acquisition
methods combining the unbiasedness of Data-Dependent Acquisition (DDA) with the
reproducibility, sensitivity, and accuracy of targeted methods‚Äã1‚Äì4‚Äã. In DIA, MS instrumentation
co-isolates and fragments multiple peptides, either in sequential isolation windows traversing an
m/z range, or all at once‚Äã1‚Äì9‚Äã. DIA has the potential to comprehensively analyze all peptides in a
sample that are above the instrument‚Äôs limit of detection.
DIA data are quantified with a chromatogram-based approach. For each peptide, several
transitions (precursor/fragment ion pairs) are monitored over time, producing a set of
chromatographic peak traces. Peak area is integrated and used as a proxy for analyte
abundance. Ideally, all transitions of a given analyte should have: 1) the same elution peak
shape, 2) relative areas mirroring the relative intensities found in their reference spectrum from
a library, 3) a low mass error, and 4) consistency across all MS runs being compared. However,
due to the complexity of DIA data, it is difficult to obtain signals that correspond to this
archetype, and data analysis remains challenging.
Several tools have been developed to analyze DIA data‚Äã10‚Äã. Each one can produce a different set
of detectable peptides and quantitative results, even with standardized samples and data sets‚Äã11‚Äã.
This variability is introduced by differences at all stages of data analysis (i.e. raw data
processing, protein database search, peak detection, transition selection, chromatogram
extraction, peak integration, and statistical analysis), each of which can affect detection and
quantification.
Most tools focus on statistical validation of peptide detection (using target/decoy approaches
12,13‚Äã

) but do not address the ‚Äãquantitative suitability of the signals extracted. Targeted analyses of

DIA data begin with spectral libraries, which may be built from a single, fractionated ‚Äúmaster
sample‚Äù using narrow isolation window DDA methodology. These practices mask the complexity
found in real DIA data and do not anticipate interferences present in real biological samples,
especially when perturbations are introduced. Therefore, transitions selected from spectral
libraries may not be suitable for quantification in actual biological sample sets. In practice,

2

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

further curation of signals is required for rigorous quantitation. During curation, an expert
visually inspects the data, removes transitions subject to interference, and manually corrects
peak integration boundaries. However, time-consuming manual curation is impractical with large
datasets, and produces subjective user-dependent results. Curation is thus often omitted and
the output of these tools is used at face-value for downstream analysis.
Missing values are also a problem in DIA approaches. They can have a biological origin (e.g.
peptides truly not present), a technical origin (e.g., peptide loss during sample processing), or a
computational origin, (e.g., failure to assign the correct signal to the respective peptide). The
latter reason can be due to retention time prediction or alignment models that improperly impute
chromatographic boundaries of the analytes in real samples. Missing data can also originate
from non-curated data. A peptide subject to interference might fail to be identified in a subset of
samples (e.g. indistinguishable from a decoy peptide), thus creating missing values even though
the peptide is present. However, if another set of interference-free transitions had been used,
this peptide might be detected in all samples, subsequently providing accurate and reproducible
quantification.
The issues discussed above motivated us to create a tool for automated targeted MS data
curation. Here we present ‚ÄãAvant-garde ‚Äã(AvG), a modular tool meant to polish the results of DIA

and PRM analysis tools. Building upon earlier work on DIA and PRM data optimization‚Äã14‚Äã, AvG
refines DIA signals to reach the highest possible levels of sensitivity, selectivity, and accuracy.
AvG refines peak detection, adjusts peak boundaries, removes transitions subject to
interference, eliminates noise, and estimates the FDR of analytes for ‚Äãquantitative suitability‚Äã.
Unlike other tools where MS runs are scored independently from each other, AvG uses a novel
ensemble data-driven scoring strategy‚Äã. DIA ‚Äãsignals are refined by learning from the data itself,
using all measurements in all samples together to achieve the best optimization.
Results
Principle of Avant-garde:
AvG i‚Äã s a tool designed for automated data curation, meant to complement common DIA
analysis tools such as mProphet‚Äã12‚Äã, OpenSWATH‚Äã13‚Äã, DIA-Umpire‚Äã15‚Äã, EncyclopeDIA‚Äã16‚Äã, and

3

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Specter‚Äã17‚Äã. To ease use and adoption of AvG, we have chosen Skyline‚Äã18 to extract
chromatogram data as a vendor-independent and user-friendly tool. It enables data visualization
and provides a common framework to refine results from different upstream tools. Skyline
requires only the peptide sequences and peak integration boundaries determined by these
tools.
AvG uses the chromatogram data and employs three independent modules to refine the data
(Fig. 1). First, a transition refinement module improves the choice of transitions to eliminate
interferences and reduce noise. Second, a peak refinement module adjusts integration
boundaries without the need for spiked-in retention time peptides. A third module scores peaks
using a number of intuitive metrics and estimates the false discovery rate (FDR) for quantitative
suitability. The refinement results and scoring metrics are then imported back into Skyline.

Figure 1: ‚ÄãAvant-garde‚Äô‚Äã s role in data analysis and modular scheme. ‚ÄãTop‚Äã: AvG is employed
downstream of independent DIA identification engines, and depends on Skyline to extract
chromatogram data of detected peptides. The output of AvG (suitable transitions,
chromatographic boundaries, and scoring metrics) is reimported to Skyline to produce curated
quantitative data. ‚ÄãBottom:‚Äã AvG is composed of three modules. Module 1 curates transitions to
reduce noise and remove interference using a genetic algorithm, assigning a final quality metric
to the selected set (‚ÄãAvG fitness score‚Äã). Module 2 refines peak integration boundaries. AvG
4

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

calculates chromatographic subscores at each time point in the raw data, and combines them
as a weighted product (‚ÄãAvG chromatographic score‚Äã). The maximum value of this score
corresponds to the most likely retention time of the analyte. Module 3 scores peaks (‚ÄãAvG score‚Äã),
filters the data and estimates the FDR for quantitative suitability.

Like other tools, AvG assigns and quantifies peptides using composite scores (built from
subscores) as the basis for quality filtering of results and estimation of the FDR. ‚ÄãEach module of
AvG produces its own composite score: the ‚Äú‚ÄãAvG fitness score‚Äã‚Äù for transition selection, the ‚Äú‚ÄãAvG

chromatographic score‚Äù‚Äã for peak integration boundaries, and the ‚Äú‚ÄãAvG score‚Äã‚Äù for the final
scoring of peaks and FDR estimation. However, its ‚Äãcomposite scores are calculated as the
product rather than the sum of its subscores. This approach avoids allowing any ‚Äãsingle
subscore to push the composite score over an arbitrary ‚Äúsignificance‚Äù threshold employed to
control the FDR. Uniquely, AvG calculates its module scores in an ensemble-driven manner,
curating transitions and peak boundaries while ‚Äãconsidering data from all samples in a set‚Äã.
The scoring strategy is designed to produce very conservative results. AvG penalizes peptides
with any single metric that indicates poor quality. This scoring mechanism imposes strong
penalties on transitions subject to interference. A high final AvG score ensures that minimal
interference is present and that the signals are suitable for quantification.
Automated refinement of transition selection by a genetic algorithm
The transition refinement module is based on a genetic algorithm (Fig. 1), which is a machine
learning method designed for solving optimization problems. Its operating principle mimics
natural selection and biological evolution, and efficiently samples a large number of
combinations without being exhaustive. ‚ÄãTo select the best set of transitions for each peptide, we
start by extracting a large number of transitions for each (‚Äãat least 5-10 per peptide). These
transitions may be subject to interference (Fig. S1). ‚ÄãFor each step (or generation), the genetic
algorithm selects several random subsets of transitions. The algorithm then scores each one
with a fitness function and selects the best-scoring solution(s) as the starting population for the
next generation. Over successive steps, the population "evolves" towards an optimal solution,

5

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

as the score of the fitness function increases until it reaches a stable maximum. The
corresponding solution is the most suitable set of transitions for quantification.
The genetic algorithm maximizes the AvG fitness score (Supp. Methods and Fig. S2). The
subscores fall into two categories: run-specific and dataset-wide scores. There are three
run-specific subscores: 1) the mass error score penalizes differences between observed and
expected masses of transitions, 2) the Spectral Library Similarity (SLS) score compares the
relative intensities of transitions to a reference spectrum using a transformation of the dot
product, and 3) the Peak Shape Similarity (PSS) score evaluates the correlation of elution
profiles of transitions. The PSS score is extremely sensitive for detection of interference.
The median profile of relative areas (MPRA) subscore is a dataset-wide score (Supp. Methods ).
In a nutshell, the MPRA measures how similar the signals in a given run are to all other runs in
the entire dataset. It evaluates the similarity of the relative peak areas of transitions in one run to
the median profile calculated on all the runs in the dataset.
For each run, the composite score is a combination of run-specific and dataset-wide scores.
This ensures that the final solution is the best possible compromise considering all runs in the
dataset and is not influenced only by a small number of high-scoring runs. It also allows the
identification of problematic runs. Finally, the ‚ÄãAvG fitness score is calculated for each peptide in
the dataset by calculating the mean of all combined scores for each run. Because the ‚ÄãAvG
fitness score is ensemble-driven, the genetic algorithm evolves towards noise-free signals,
reduced interference, and consensus in quantifiable transitions across the entire dataset.
Automated refinement of peak integration boundaries
AvG uses the curated transitions to adjust peak boundaries without the need for retention time
alignment. Several chromatographic subscores are calculated at each time point in the raw data
(Fig. 1). The ‚ÄãAvG chromatogram score is also calculated in an ensemble-driven manner as a
product of subscores (Supp. Methods). The objective is to penalize peptides with any single
metric that indicates poor quality. The maximum value of the AvG chromatogram score
corresponds to a peak‚Äôs most likely retention time.

6

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Fig. 1 (box 2) shows an example of the cumulative effect of transition curation and peak
boundary refinement for a peptide. Initially, the integration boundaries (from Skyline) did not
correspond to the real chromatographic peak. AvG focuses on signals that are potential peptide
peaks, where for each point at least 3 non-zero transitions are observed. For potential peaks,
the SLS and the MPRA are calculated. In the example, some subscores (SLS, MPRA, and the
mass error) are low in the time range corresponding to the initial peak integration boundaries.
The ‚ÄãAvG chromatographic score has a low value close to zero in that time window, even though
the intensity scores are high. However, the maximum value of the ‚ÄãAvG chromatographic score
corresponds to the real retention time of the analyte. The peak boundaries are then defined
around this time, guided by the ‚ÄãAvG chromatographic score and the ‚ÄãIntensity (sum) subscore‚Äã.
Prior knowledge of approximate retention time can improve the speed of this module, but is not
a requirement (see Supp. Fig. 3 for the same example over a wider time window). When a
peptide is not present in a sample for biological or technical reasons, AvG still integrates the
signal around the maximum value of the ensemble-driven ‚ÄãAvG chromatographic score.‚Äã
AvG identifies DIA signals with high quantitative suitability
After curation of transitions and peak boundaries, all signals are scored again with the third
module to assess overall quality, and suitability for quantification (Supp. Methods). As described
above, the scoring mechanism was designed to discriminate poor- from high-quality signals with
respect to quantitative suitability. To evaluate the selectivity, precision, accuracy, and FDR of
AvG results, a five-point calibration curve (5 samples analyzed in triplicate) was built using a
background of HEK293T whole cell digest spiked with 95 synthetic phosphopeptides. The
calibration curve ranged from 6.75 ng to 108 ng of total synthetic peptide mixture spiked into 1
Œºg of HEK293T digest per injection. Each sample was measured in triplicate on a Q-Exactive
HF using a DIA method (Supp. Methods).
First, we determined the FDR for ‚Äãquantitative suitability after curation with AvG using a
target-decoy approach. To do this, we randomly selected 1000 human peptides that were
identified in previous DDA runs of the same digest. Their signals and their corresponding
shuffled-sequence decoys were extracted from DIA runs and were automatically curated using
AvG.

7

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

The distributions of each subscore (Fig. S4) discriminate between targets and decoys with
varying performance. However, a weighted product of the subscores produces an extremely
good separation of the distributions. We empirically determined the exponent weights for the
multiplicative combination of the AvG subscores. However, we verified that the results obtained
with our weights matched the results with weights obtained by linear discriminant analysis
(Supp. Methods and Fig. S5) with respect to overall sensitivity. Most decoys have an AvG score
close to 0 (98% < 0.05) and the cutoff to obtain an FDR below 1% was a value equal to 0.11.
AvG additionally enforces minimum thresholds for each subscore (SLS > 0.7, mass error score
> 0.7, PSS > 0.85, MPRA > 0.9) to remove poor signals (Fig. S4). Filtering by these thresholds
does not alter the total number of analytes marked as suitable for quantification and the FDR
remained below 1% (Fig. S6). A final ‚ÄãAvG score threshold of 0.1 was adopted. FDRs computed
using these thresholds were always < 1.0%.
AvG ensures high accuracy and precision
The precision and accuracy of AvG were evaluated using the dilution series of the 95 synthetic
phosphopeptides that were spiked into the HEK293T digest. A typical AvG performance on the
spiked-in synthetic peptide S[+80]LTAHSLLPLAEK is shown in Fig. 2A. Skyline‚Äôs initial
extraction of signals from this peptide is incorrect in some runs, due to misassignment of peak
boundaries. These aberrant signals cause departure from the expected linear relationship
between concentration and peak area (‚Äãr2‚Äã = 0.44, Fig. 2A, top). After curation by AvG, the
expected linear relationship is recovered (‚Äãr‚Äã2‚Äã = 0.99, Fig. 2A, bottom).

There was marked improvement for aggregate measurements of all 95 synthetic peptides after
application of AvG (as compared to initial, unoptimized Skyline extractions) in several figures of
merit (Fig. 2B). The precision, measured by the CVs of triplicates, improved from 43.2% to
5.6%. The correlation coefficient between peptide concentration and peak area improved from
r‚Äã2‚Äã=0.85 to ‚Äãr2‚Äã‚Äã =0.99. Improvements in the fraction of measurements with less than 20% absolute
error (our definition of accuracy, see Supp. Methods) were also evident. Finally, the relative
quantification accuracy was also evaluated. We calculated the ratios between the mean area of
each calibration point to the mean area of the fourth calibration point (P4 in Fig. 2C). The

8

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

distribution of measured ratios after AvG refinement is clearly much tighter and closer to the
expected values.

Figure 2: AvG improves quantitative figures-of-merit in a calibration curve. 95 synthetic
phosphopeptides were spiked into a HEK293T whole cell digest to create a 5-point calibration
curve (5 samples were analyzed in triplicate). (A) Calibration curve before (top) and after
(bottom) curation by AvG for peptide S[+80]LTAHSLLPLAEK. In this case, AvG automatically
corrected the peak boundaries for this peptide improving curve linearity. (B) Figures-of-merit
summarising the results for all synthetic peptides, pre- and post-optimization: % CV of
triplicates, ‚Äãr‚Äã2 ‚Äãvalues of linear fits, and absolute percent error of measurements relative to the
known concentration. Dashed lines indicate 20% thresholds. The box plot elements are: center
line, median; box limits, upper and lower quartiles; whiskers, 1.5x interquartile range; points,
outliers (C) Expected vs. observed ratiometric quantification, pre- and post-optimization. P1 to
P5 represent the points of the calibration curve in increasing order of concentration. The ratios
between the mean area of each calibration point to the mean area of the fourth calibration point
(P4) are shown here. The dashed lines represent the expected ratios (0.125, 0.25, 0.5 and 2)
and the boxplots show the distribution of the measured ratios. The boxplot elements are the
same as described for panel B.

AvG results are concordant with expert manual curation

9

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

To further evaluate the performance of the automated data curation, we applied AvG to a
reduced-representation phosphoproteomics dataset obtained for our LINCS project‚Äã19‚Äã. This
dataset, acquired in DIA mode, had previously been manually curated by an expert in our
laboratory, which we consider the gold-standard against which other approaches were
compared. We curated data across 96 samples for 95 phosphopeptides for which
isotopically-labeled heavy peptide counterparts were present. For the ‚Äúunoptimized‚Äù analysis,
the 5 most intense transitions from the spectral library were chosen and the peak boundaries
were defined by Skyline. For the optimized version, all possible b- and y-ions above b‚Äã4 and y‚Äã4
were extracted and subjected to further curation by AvG. AvG was run in two modes: 1) ‚Äúopen‚Äù
curation, where no subscore or composite score filters were applied, and 2) ‚Äúfiltered‚Äù curation,
where subscore filters were introduced (see discussion of filtering above).
The comparison of light-to-heavy ratios between the manually curated and unoptimized
analyses (Fig. 3A) had many points deviating from the ideal x=y line. After ‚Äúopen‚Äù curation by
AvG (Fig. 3B), many fewer points deviated from this line. The disagreements that remained
could be explained by peptides where AvG chose different transitions than the manual curator,
producing discrepant light-to-heavy ratios. These differences were enhanced if either the light or
the heavy peptide had low intensity. In that case, any small change in the signal would have a
large impact on the ratio. The results of filtered curation correlated even better with manual
curation (r=0.99, Fig. 3C). Signals creating discrepancies in the open curation analysis were
filtered out showing that they were derived from low-quality data.
Additionally, AvG improved the data completeness. Analysis of 190 precursors and 18240
individual measurements was theoretically possible (95 peptides x 2 isotopic label states x 96
samples). AvG improved the data completeness over unoptimized analysis and even manual
curation (19% and 12%, respectively, at the measurement level, Fig. 3D). Overall, the data
curation by AvG enabled the quantification of 92% of all peptides with data completeness of
79%. AvG performed its curation of this dataset in < 1 hr of unsupervised time, while typically it
takes a manual curator > 10 hours of ‚Äúhands-on‚Äù work.

10

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Figure 3: Avant-garde equals the performances obtained by expert visual inspection and
manual validation.
We focused on 95 phosphopeptides, and their isotopically labeled heavy peptide counterparts,
analyzed in a cohort of 96 phospho-enriched samples. The dataset was initially analyzed using
Skyline and manually curated by an expert. The scatter plots compare results of light-to-heavy
ratios of the (A) unoptimized dataset, (B) the AvG ‚Äúopen‚Äù curation dataset, and (C) the AvG
filtered curation dataset to the manually curated dataset. (D) Data completeness measured after
filtering the data for quantitative suitability at the measurement and at the analyte level.
Evaluation of AvG with LFQBench
We asked whether AvG could further improve quantification when applied to the leading DIA
benchmarking dataset in the field, LFQBench‚Äã11‚Äã, as compared to the many tools with which it has
already been analyzed. This dataset was collected on a time-of-flight mass spectrometer,
resulting in different data characteristics (resolution, mass accuracy, baseline noise level) than
the Orbitrap-class data on which AvG was developed.

11

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

The example shown in Fig. 4 compares the basic Skyline analysis to the AvG curation of the
LFQBench HYE110 dataset, acquired with a SWATH method with 64 variable m/z windows‚Äã11‚Äã.
The two samples are each mixtures of three complex proteomes - ‚ÄãE. coli‚Äã, human and yeast formulated as shown in Fig. 4A. Three expected ratios are possible when comparing sample A
to B (0.1, 1 and 10 for the ‚ÄãE. coli,‚Äã human and yeast peptides respectively). The results extracted
using Skyline show that a large number of ratio data points deviate from the expected values
(Fig. 4B). Even the ‚Äãcenters of the distributions of ratios for the non-human proteomes did not
match their expected values. The median percent errors were 373% for ‚ÄãE. coli and 84% for
yeast. These deviations also affected the precision of the measurement, calculated for triplicate
values (median CV of 15.1%, 7.3%, and 19.3% for ‚ÄãE. coli‚Äã, human and yeast peptides
respectively, Fig. 4D).
After curating and filtering the data with AvG, the ratio distributions were much closer to the
expected values (Fig. 4C). The median A/B ratio for each proteome was 0.11 ¬± 0.015 for ‚ÄãE. coli‚Äã,
1.03 ¬± 0.09 for human, and 11.24 ¬± 1.91 for yeast. The precision improved dramatically (median
CV of 5.8%, 5.7 %, and 6%; Fig. 4D), as did the accuracy (median % error 5% and 19% for ‚ÄãE.
coli‚Äã and yeast respectively; Fig. 4E).
AvG produced very conservative results. The total number of reported peptides after curation
was lower than initially reported by the upstream tools. We wanted to evaluate the quality of the
data in both pre- and post-curation analyses. To do this, we ‚Äúmarked‚Äù peptides as suitable for
quantification by independently applying AvG‚Äôs third scoring/filtering module (Supp. Meth., and
Figs. S7 and S8). In the unoptimized analysis, only 34% of over 240,000 initially reported
measurements were marked as suitable according to our metrics. After the signal curation by
AvG this fraction increased to 52%. This implies that AvG improves the number of peptides that
can be quantified accurately and precisely (Fig. 4F), but that the quantitative suitability for a
large number of analytes remained suspicious.

12

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Figure 4: Evaluation of AvG with LFQBench data. (A) The composition of the LFQBench
samples by species proteome. (B,C) Results of the relative quantification and distribution of the
experimental ratios obtained in the unoptimized dataset (B) and the AvG-curated dataset (C).
Each dot represents a ratio calculated for a given peptide in a given run. The dashed lines
represent the expected ratios. (D) The coefficient of variation and (E) the percent error for each
proteome for the uncurated (top) and curated (bottom) dataset are shown. The vertical dashed
lines demarcate the 20% threshold. The box plot elements are: center line, median; box limits,
upper and lower quartiles; whiskers, 1.5x interquartile range; points, outliers. (F) The
percentage of measurements meeting the criteria for quantitative suitability (AvG module 3) is
shown before and after curation with AvG.

Extended benchmarking of AvG demonstrates that it produces precise and accurate data

13

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

To further evaluate AvG, we created a complex benchmarking set of 4 samples consisting of a
mixture of three complex proteomes. The total amount of protein and the proportion of the
human proteome was kept constant in all samples, while the proportion of ‚ÄãE. coli and yeast
varied (Table 1, Fig. S9). Six pairwise combinations of the samples are possible, resulting in 12
‚Äúground truth‚Äù ratios ranging from 1.2-fold to 10-fold, plus a constant 1:1 ratio of human peptides
for all possible comparisons. This experimental design enabled the estimation of reproducibility
across many MS runs having different sample compositions, with some compositions more
prone to interferences than others.

Table 1: Expected ratios of the pairwise relative quantification of samples in the extended
benchmarking dataset. From the 4 samples, 6 pairwise combinations can be obtained for
relative quantification. This table summarizes the expected ratios for each proteome and each
comparison.
The resulting dataset has a large peptide abundance dynamic range and emulates ratios close
to typical thresholds of biological significance for evaluation of DIA analysis tools‚Äã11,20‚Äã. We report
results at the peptide level (not protein level), as it more accurately reflects the direct
measurements made by the mass spectrometer. Protein ‚Äúroll-up‚Äù can mask peptide
inaccuracies. We used our DIA benchmarking dataset to evaluate the results of the widely-used
mProphet tool compared to data curation with AvG.
The results of the relative quantification accuracy for the baseline mProphet analysis (Fig.
S10A) showed high variance and large deviations from the expected values. This phenomenon
was readily observed when examining the distribution of ratios for the human peptides, which all
should have a nominal ratio of 1:1 in comparing any two samples (Fig. S10A, bottom panel).
While these large deviations were more prominent at low intensity, they were observed
throughout the entire intensity range. Summarizing across all 6 pairwise comparisons, we
observed MAD = 0.20 and ùúé=1.94 around the expected ratio of 1:1. In practical terms, this

14

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

means that any ratio derived from mProphet results ranging from 0.25:1 to 4:1 (+/- 2ùúé) was not
statistically different from 1:1. Relative quantification of the pre-defined ratios for the ‚ÄãE. coli and
yeast peptides was also poor, with a mean percent error of 59% for ‚ÄãE. coli‚Äã-derived ratios and
178% for yeast peptides.
After refining the same dataset using AvG, relative quantification accuracy improved
dramatically (Fig. S10B). Summary statistics for the human peptides improved to MAD = 0.13
and ùúé=0.27, allowing detection of significant differences at a threshold of 1.54-fold. Relative
quantification of the post-defined ratios for the ‚ÄãE. coli and yeast peptides improved, with a mean
percent error of 17% for ‚ÄãE. coli‚Äã-derived ratios and 18% for yeast peptides. The FDR calculated
after refinement was 0.15% at the measurement level and 0.3% at the peptide level. When
scoring mProphet results with AvG metrics, it is clear that many peaks would fall below
thresholds that we considered reliable for quantification (Fig. S10C). Improvement in all figures
of merit (CV, accuracy, % error, and linear goodness-of-fit) was observed after AvG curation
(Fig. S10D). While the total number of peptide analytes dropped after AvG curation, we are
confident that these were the most reliable for use in downstream quantitative analyses.
Performance of AvG under conditions emulating real biological data
Detection of changes in protein levels between two sample classes (e.g., diseased vs. healthy,
treated vs. control) is a major paradigm for quantitative proteomics. To evaluate whether AvG
curation would help achieve this goal, we simulated biological data to create a realistic scenario
in which most peptides in the data set were ‚Äúunchanged,‚Äù while a small minority were up- or
down-regulated. This was practically achieved by downsampling the benchmarking data to
include 90% human analytes (3000 peptides, unchanged), 5% ‚ÄãE. coli ‚Äãpeptides (positive
fold-changes), and 5% yeast peptides (negative fold-changes). The analytes were chosen at
random from the larger pool of peptides, allowing us to bootstrap the analysis by selecting
different subsets.
We calculated ratios of peptides between the different sample compositions before and after
AvG curation, and compared them to the expected ratios (Table 1). Significance (‚Äãp‚Äã) values were
assigned to the ratios using a moderated t-test and corrected for multiple hypothesis testing‚Äã21‚Äã.

Peptides were classified as differentially expressed if their adjusted ‚Äãp‚Äã-value was lower than 0.05
15

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

and their absolute fold change was > 2œÉ of the fold changes for the (unchanged) human
peptides present in the downsampled data, and considered ‚Äúaccurate‚Äù if their observed ratio
was 80-120% of expected. Knowledge of the species-of-origin for each peptide allowed us to
classify results as true- or false-positive.
AvG improved the ability to detect changes in protein expression. As an example, we compared
sample A to B before and after AvG curation (Fig. 5A). The improved accuracy and precision
obtained after AvG resulted in a much higher number of true positive hits (blue and red full
disks) and lower number of false positives hits (green full disks not within the grey area).
Additionally, the number of accurate measurements (observations between the dashed lines)
increased after curation.
To quantify the improvement in performance, we calculated the recall, % of ‚Äúaccurate‚Äù
measurements, and false positive rates for detection of differentially expressed peptides across
the range of fold-changes using 1000 bootstrap iterations as described in Supp. Methods. The
results are illustrated in Fig. 5B, with the shaded areas indicating improvement in
figures-of-merit achieved after AvG curation. AvG increased the recall and led to a higher
number of correct calls of significance for differentially expressed peptides (Fig. 5B, left). After
curation, a recall higher than 95% was achieved for any absolute fold change above 2.0. In
comparison, unoptimized data could only achieve a recall of ~80% even for 10-fold changes. In
addition, we observed an improvement in the percentage of true positive hits that were
classified as being ‚Äãaccurate‚Äã, with a median improvement of 47% (Fig. 5B, middle). Furthermore,
the false positive rate decreased from a median value of 38% to a median of 25%.
The presence of the unchanging proportion of human peptides across all samples allowed us to
estimate the minimum detectable fold change (estimated as Œº +/- 2œÉ) before and after data
curation. The threshold for uncurated data was 2.3-fold, but fell to 1.4-fold after AvG. Sensitivity
(recall) was 70% at this threshold, and 85% of the differential peptides had a calculated ratio
within 20% of the true ratio. This demonstrated that we can confidently detect relatively small
changes in peptide abundance with properly curated data.

16

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

Figure 5: Detection of differentially expressed peptides in unoptimized and curated data. (A) An
example of a pairwise comparison (sample A vs. B), with volcano plots of unoptimized (left) and
curated (right) data. Each point represents an E. Coli (red), Yeast (blue) or Human (green)
peptide. The shaded regions demarcate ranges where detection of differential expression is not
statistically viable. The dashed lines represent accuracy boundaries of +/- 20%.(B) Bootstrap
(n=1000) analysis of downsampled datasets for recall (sensitivity), accuracy, and false positive
rate. Shaded regions indicate improvement in area under the curve after AvG curation. Error
bars connote the standard deviation across bootstrap iterations.
Discussion
Data curation is an extremely important but often overlooked step in transition-based
quantitative proteomics. We have demonstrated that AvG can curate DIA data in an automated
manner. ‚ÄãA‚ÄãvG tailors the choice of transitions to each dataset to minimize noise and increase the
reliability of quantification. A key feature of AvG is that each peptide is reassessed with an
independent global scoring module after curation to estimate a dataset-level FDR for
quantitative suitability,‚Äã not just detection. Counterintuitively, the number of detected peptides
may go down after AvG, but the quality of quantitation for those peptides will be higher. We
have empirically demonstrated that the AvG score tends to be low for ‚Äúdecoy‚Äù analytes, and

17

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

data curated with AvG consistently produces FDRs < 1.0% at the thresholds we have defined.
Other software tools for DIA analysis typically simply extract the 5-10 most intense transitions
from the spectral library. This approach does not guarantee interference-free transitions for
analyzing complex biological samples, where curation is paramount.
An alternative approach is to select the transitions that are predicted to be unique to their
precursor ion using tools like SRMCollider‚Äã22‚Äã. However, interferences are difficult to predict due
to run-to-run chromatographic variability and changes in sample composition. These tools do
not consider retention time or fragment ion intensities, hindering accurate curation. ‚ÄãA priori
prediction of interference, reliant on protein databases and other user choices, does not
anticipate

real-world

LCMS

data

artifacts.

Another

‚Äãa

priori

approach

to curation,

SWATHProphet‚Äã23‚Äã, uses spectral libraries embedded with retention time information to anticipate
quantitative interferences. In this case, library completeness (again traceable to experimental
and user decisions) governs the success of the approach. In contrast, AvG uses an ‚Äãa posteriori
approach to curate data that explicitly considers LCMS artifacts ‚Äãand utilizes prior knowledge but
is not limited by it.
SWATHProphet, based on the mProphet discriminant score, also implements an approach for ‚Äãa
posteriori flagging of poor transitions. Its application requires iterative cycles of optimization and
data re-extraction, and again relies on spectral libraries as the primary source of interference
detection. Further, it focuses on improving quantitation for peptides that already have a high
mProphet score, rather than potentially improving scores of borderline peptides. This approach
is apt to produce false negatives and will fail to rescue suitable data signals. AvG focuses on
identifying the ‚Äúcleanest‚Äù transitions that are the best suited for quantification, and can improve
signal quality for marginal cases. It does not require iterative cycles and is not bound to any
specific DIA or PRM workflow, as it is fully implemented as an external tool in Skyline.
The objective of quantitative proteomics is to identify differentially expressed proteins or
peptides. Therefore, it is important to evaluate new methods with scenarios that mimic
conditions found in real biological milieux. For us, that meant creating a dataset where the
majority of peptide analytes were unchanged between two sample classes, while a minority
were changing with a known ratio. Moreover, we needed to evaluate ranges of borderline
biological significance (1.5 - 2.0-fold) as well as extreme significance (>5-fold) to truly assess

18

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

method performance. By downsampling and bootstrapping a very large DIA dataset of mixed
multi-species proteomes, we could evaluate 1000s of such simulated datasets to test the
robustness of AvG. We were pleased to find that AvG could enable discrimination of changes as
low as 1.4-fold with fairly high sensitivity and accuracy, and that, across the board, it can add
value to the work done by other DIA analysis tools by improving ‚Äãquantitative suitability of the
data. To us, this means that it can help produce more accurate and reproducible quantification
results, providing more granularity in the elucidation of the complex dynamics of proteomes.
AvG‚Äôs ensemble-driven scoring strategy is designed to produce very conservative results by
penalizing poor-quality signals. Its combined score is a weighted product of run-specific and
dataset-wide subscores that intuitively map to common LCMS data quality metrics. AvG
penalizes sets of transitions for peptides with any single poorly-scoring metric, making it very
sensitive to interferences. However, its evolutionary optimization approach ultimately selects
sets of transitions that produce the lowest levels of noise and the highest level of parsimony for
signals across the entire dataset. Application of AvG improves selectivity, accuracy, and
reproducibility of quantitative DIA proteomics data. The resulting curated data is comparable to
the current gold-standard of expert human curation, but obtainable in a fraction of the time.
AvG‚Äôs compatibility with a variety of acquisition modes (DIA or PRM), data sources (e.g.
Orbitrap and TOF), upstream DIA identification tools (e.g. EncyclopeDIA, Specter, mProphet,
etc.), and Skyline integration should make it attractive for broad utilization in the field.
Acknowledgements
The authors would like to thank Nicholas Pythoud, Joanna Bons, Alexandre Burel and Christine
Carapito for beta-testing the software. This work was funded by U54 HG008097 to JDJ.
Author Contributions
A.S.V.J. conceived of the idea, designed and performed experiments, collected the data,
authored software, and wrote the manuscript. R.P. provided help with the data analysis of the
benchmarking datasets. N.S. and B.M. adapted Skyline to facilitate the use of Avant-garde as
an External tool. K.K. provided help with the statistical analysis of the benchmarking datasets.
K.C.D. and A.O. carried out experiments and collected data for the P100 dataset, and

19

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

beta-tested the software. M.J.M. and S.A.C. provided laboratory resources and guidance on the
manuscript. J.D.J. provided laboratory resources, provided input on the software, provided
guidance on the experimental design and wrote the manuscript.
Conflicts of Interest
JDJ declares no conflicts of interest.
Code availability:
Avant-garde DIA is an open-source software tool available as an R package and as an Skyline
External tool at ‚Äãhttps://github.com/SebVaca/Avant_garde‚Äã. Avant-garde can be directly
downloaded from tool Store interface within Skyline or from the Skyline tool Store at
https://skyline.ms/skyts/home/software/Skyline/tools/details.view?name=AvantGardeDIA‚Äã.

Data availability:
The data that support the findings of this study are available from the corresponding author
upon request.

20

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

References

1.

Panchaud, A. ‚Äãet al.‚Äã Precursor acquisition independent from ion count: how to dive deeper
into the proteomics ocean. ‚ÄãAnal. Chem.‚Äã ‚Äã81‚Äã, 6481‚Äì6488 (2009).

2.

Gillet, L. C. ‚Äãet al.‚Äã Targeted data extraction of the MS/MS spectra generated by
data-independent acquisition: a new concept for consistent and accurate proteome
analysis. M
‚Äã ol. Cell. Proteomics‚Äã ‚Äã11‚Äã, O111.016717 (2012).

3.

Egertson, J. D. ‚Äãet al.‚Äã Multiplexed MS/MS for improved data-independent acquisition. ‚ÄãNat.
Methods‚Äã ‚Äã10‚Äã, 744‚Äì746 (2013).

4.

Chapman, J. D., Goodlett, D. R. & Masselon, C. D. Multiplexed and data-independent
tandem mass spectrometry for global proteome profiling. ‚ÄãMass Spectrom. Rev.‚Äã ‚Äã33‚Äã,
452‚Äì470 (2014).

5.

Purvine, S., Eppel*, J.-T., Yi, E. C. & Goodlett, D. R. Shotgun collision-induced dissociation
of peptides using a time of flight mass analyzer. ‚ÄãProteomics‚Äã ‚Äã3‚Äã, 847‚Äì850 (2003).

6.

Silva, J. C. ‚Äãet al.‚Äã Quantitative proteomic analysis by accurate mass retention time pairs.
Anal. Chem.‚Äã ‚Äã77‚Äã, 2187‚Äì2200 (2005).

7.

Silva, J. C. ‚Äãet al.‚Äã Simultaneous qualitative and quantitative analysis of the Escherichia coli
proteome: a sweet tale. M
‚Äã ol. Cell. Proteomics‚Äã ‚Äã5‚Äã, 589‚Äì607 (2006).

8.

Prakash, A. ‚Äãet al.‚Äã Hybrid data acquisition and processing strategies with increased
throughput and selectivity: pSMART analysis for global qualitative and quantitative analysis.
J. Proteome Res.‚Äã ‚Äã13‚Äã, 5415‚Äì5430 (2014).

9.

Geiger, T., Cox, J. & Mann, M. Proteomics on an Orbitrap benchtop mass spectrometer
using all-ion fragmentation. ‚ÄãMol. Cell. Proteomics‚Äã ‚Äã9‚Äã, 2252‚Äì2261 (2010).

10. Bilbao, A. ‚Äãet al.‚Äã Processing strategies and software solutions for data-independent

21

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

acquisition in mass spectrometry. ‚ÄãProteomics‚Äã ‚Äã15‚Äã, 964‚Äì980 (2015).
11. Navarro, P. ‚Äãet al.‚Äã A multicenter study benchmarks software tools for label-free proteome
quantification. ‚ÄãNat. Biotechnol.‚Äã ‚Äã34‚Äã, 1130‚Äì1136 (2016).
12. Reiter, L. ‚Äãet al.‚Äã mProphet: automated data processing and statistical validation for
large-scale SRM experiments. ‚ÄãNat. Methods‚Äã ‚Äã8‚Äã, 430‚Äì435 (2011).
13. R√∂st, H. L. ‚Äãet al.‚Äã OpenSWATH enables automated, targeted analysis of data-independent
acquisition MS data. ‚ÄãNat. Biotechnol.‚Äã ‚Äã32‚Äã, 219‚Äì223 (2014).
14. Jaffe, J. D., Feeney, C. M., Patel, J., Lu, X. & Mani, D. R. Transitioning from Targeted to
Comprehensive Mass Spectrometry Using Genetic Algorithms. ‚ÄãJ. Am. Soc. Mass
Spectrom.‚Äã ‚Äã27‚Äã, 1745‚Äì1751 (2016).
15. Tsou, C.-C. ‚Äãet al.‚Äã DIA-Umpire: comprehensive computational framework for
data-independent acquisition proteomics. ‚ÄãNat. Methods‚Äã ‚Äã12‚Äã, 258‚Äì64, 7 p following 264
(2015).
16. Searle, B. C. ‚Äãet al.‚Äã Comprehensive peptide quantification for data independent acquisition
mass spectrometry using chromatogram libraries. ‚ÄãbioRxiv‚Äã 277822 (2018).
doi:‚Äã10.1101/277822
17. Peckner, R. ‚Äãet al.‚Äã Specter: linear deconvolution for targeted analysis of data-independent
acquisition mass spectrometry proteomics. ‚ÄãNat. Methods‚Äã ‚Äã15‚Äã, 371‚Äì378 (2018).
18. MacLean, B. ‚Äãet al.‚Äã Skyline: an open source document editor for creating and analyzing
targeted proteomics experiments. ‚ÄãBioinformatics‚Äã ‚Äã26‚Äã, 966‚Äì968 (2010).
19. Abelin, J. G., Patel, J., Lu, X., Feeney, C. M. & Fagbami, L. Reduced-representation
phosphosignatures measured by quantitative targeted MS capture cellular states and
enable large-scale comparison of drug-induced ‚Ä¶. ‚ÄãMolecular & Cellular‚Äã (2016).
20. Ramus, C. ‚Äãet al.‚Äã Benchmarking quantitative label-free LC-MS data processing workflows

22

bioRxiv preprint doi: https://doi.org/10.1101/565523; this version posted March 1, 2019. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
aCC-BY-NC-ND 4.0 International license.

using a complex spiked proteomic standard dataset. ‚ÄãJ. Proteomics‚Äã ‚Äã132‚Äã, 51‚Äì62 (2016).
21. Ritchie, M. E. ‚Äãet al.‚Äã limma powers differential expression analyses for RNA-sequencing and
microarray studies. ‚ÄãNucleic Acids Res.‚Äã ‚Äã43‚Äã, e47 (2015).
22. R√∂st, H., Malmstr√∂m, L. & Aebersold, R. A computational tool to detect and avoid
redundancy in selected reaction monitoring. ‚ÄãMol. Cell. Proteomics‚Äã ‚Äã11‚Äã, 540‚Äì549 (2012).
23. Keller, A., Bader, S. L., Shteynberg, D., Hood, L. & Moritz, R. L. Automated Validation of
Results and Removal of Fragment Ion Interferences in Targeted Analysis of
Data-independent Acquisition Mass Spectrometry (MS) using SWATHProphet. ‚ÄãMol. Cell.
Proteomics‚Äã ‚Äã14‚Äã, 1411‚Äì1418 (2015).

23

